Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Neurological Sciences

• Publication date

  2017-05-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jns.2017.03.031PMID 28431620
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroinflammation and Alzheimer's Disease: Implications for Microglial Activation.

  2017cited by this paper
• Neuroprotective effects of curcumin on endothelin-1 mediated cell death in hippocampal neurons

  2017cited by this paper
• The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ

  2016cited by this paper
• Lipocalin-2 as a therapeutic target for brain injury: An astrocentric perspective.

  2016cited by this paper
• Neuroinflammation and Neurodegeneration

  2016cited by this paper
• NGF controls APP cleavage by downregulating APP phosphorylation at Thr668: relevance for Alzheimer's disease

  2016cited by this paper
• Accumulation of amyloid-β by astrocytes result in enlarged endosomes and microvesicle-induced apoptosis of neurons

  2016cited by this paper
• Diverse functional roles of lipocalin-2 in the central nervous system.

  2015cited by this paper
• Engineering superactive granulocyte macrophage colony‐stimulating factor transferrin fusion proteins as orally‐delivered candidate agents for treating neurodegenerative disease

  2015cited by this paper
• Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice.

  2015cited by this paper
• Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer’s disease

  2015cited by this paper
• APOE genotype‐dependent modulation of astrocyte chemokine CCL3 production

  2015cited by this paper
• CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.

  2015cited by this paper
• Neuroinflammation in Alzheimer’s disease

  2015cited by this paper
• Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease

  2015cited by this paper
• Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease

  2015cited by this paper
• Il10 deficiency rebalances innate immunity to mitigate Alzheimer-like pathology.

  2015influential reference
• Migration of blood cells to β-amyloid plaques in Alzheimer’s disease

  2015cited by this paper
• ApoE4 and Aβ Oligomers Reduce BDNF Expression via HDAC Nuclear Translocation

  2015cited by this paper
• Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.

  2015cited by this paper
• Neuroinflammation in Alzheimer's disease: chemokines produced by astrocytes and chemokine receptors.

  2014cited by this paper
• The Potential Role of Chemokines in Alzheimer’s Disease Pathogenesis

  2014influential reference
• Plasma amyloid-β oligomers and soluble tumor necrosis factor receptors as potential biomarkers of AD.

  2014cited by this paper
• A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects

  2014cited by this paper
• Type-1 interferon signaling mediates neuro-inflammatory events in models of Alzheimer's disease.

  2014cited by this paper
• Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease.

  2014cited by this paper
• Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease

  2014cited by this paper
• Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches

  2014cited by this paper
• In vivo administration of granulocyte colony‐stimulating factor restores long‐term depression in hippocampal slices prepared from transgenic APP/PS1 mice

  2014cited by this paper
• IFN-γ and TNF-α Are Involved During Alzheimer Disease Progression and Correlate with Nitric Oxide Production: A Study in Algerian Patients

  2014cited by this paper
• Characterization of inflammatory biomarkers and candidates for diagnosis of Alzheimer’s disease

  2014cited by this paper
• Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events.

  2014cited by this paper
• The Complement System

  2014cited by this paper
• Diagnostic methods and biomarkers for Alzheimer’s disease

  2014cited by this paper
• When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.

  2014cited by this paper
• Role of complement systems in IVIG mediated attenuation of cognitive deterioration in Alzheimer's disease.

  2014cited by this paper
• Age-related brain expression and regulation of the chemokine CCL4/MIP-1β in APP/PS1 double-transgenic mice.

  2014cited by this paper
• Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.

  2014cited by this paper
• Lipoprotein-associated phospholipase A2 and risk of dementia in the Cardiovascular Health Study.

  2014cited by this paper
• Modulation of inflammation in transgenic models of Alzheimer’s disease

  2014cited by this paper
• Modulating nitric oxide signaling in the CNS for Alzheimer's disease therapy.

  2013cited by this paper
• Granulocyte colony stimulating factor (GCSF) improves memory and neurobehavior in an amyloid-β induced experimental model of Alzheimer's disease.

  2013cited by this paper
• Th17 Cell-Mediated Neuroinflammation Is Involved in Neurodegeneration of Aβ1-42-Induced Alzheimer’s Disease Model Rats

  2013cited by this paper
• Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain

  2013cited by this paper
• Oligomeric amyloid β induces IL-1β processing via production of ROS: implication in Alzheimer's disease

  2013cited by this paper
• Microglia and monocyte-derived macrophages: functionally distinct populations that act in concert in CNS plasticity and repair

  2013cited by this paper
• A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease.

  2013cited by this paper
• Inflammatory process in Alzheimer's Disease

  2013cited by this paper
• CCL2 affects β-amyloidosis and progressive neurocognitive dysfunction in a mouse model of Alzheimer's disease.

  2013cited by this paper
• Alzheimer disease: Prostaglandin E2 signalling is implicated in inflammation early in the Alzheimer disease course

  2012cited by this paper
• Molecular cloning, characterization and expression analysis of the tumor necrosis factor (TNF) superfamily gene, TNF receptor superfamily gene and lipopolysaccharide-induced TNF-α factor (LITAF) gene from Litopenaeus vannamei.

  2012cited by this paper
• Complement activation as a biomarker for Alzheimer's disease.

  2012cited by this paper
• Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.

  2012cited by this paper
• Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells

  2012cited by this paper
• Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis

  2012cited by this paper
• A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines

  2012cited by this paper
• Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition

  2012cited by this paper
• [Pentraxin 3].

  2012cited by this paper
• Decreased expression of CCL3 in monocytes and CCR5 in lymphocytes from frontotemporal dementia as compared with Alzheimer's disease patients.

  2012cited by this paper
• Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

  2012cited by this paper
• Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer’s disease

  2012cited by this paper
• Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease.

  2012cited by this paper
• Interleukin 1 receptor antagonist reduces lethality and intestinal toxicity of 5-Fluorouracil in a mouse mucositis model.

  2011cited by this paper
• Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis

  2011influential reference
• The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide

  2011cited by this paper
• Reduced plasma levels of P-selectin and L-selectin in a pilot study from Alzheimer disease: relationship with neuro-degeneration

  2011cited by this paper
• Astrocytes contain amyloid‐β annular protofibrils in Alzheimer's disease brains

  2011cited by this paper
• Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases

  2011cited by this paper
• Lipoprotein associated phospholipase A2: role in atherosclerosis and utility as a biomarker for cardiovascular risk

  2011cited by this paper
• Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes.

  2011cited by this paper
• Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer's disease.

  2011cited by this paper
• FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders

  2011cited by this paper
• Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease

  2011cited by this paper
• Correction for Kiyota et al., FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders

  2011cited by this paper
• Increased plasma levels of lipocalin 2 in mild cognitive impairment.

  2011cited by this paper
• Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.

  2011cited by this paper
• Correlation analysis of capillary APOE, VEGF and eNOS expression in Alzheimer brains.

  2011cited by this paper
• Macrophage colony-stimulating factor and its receptor signaling augment glycated albumin-induced retinal microglial inflammation in vitro

  2011cited by this paper
• Hepatocyte growth factor promotes an anti-inflammatory cytokine profile in human abdominal aortic aneurysm tissue.

  2011cited by this paper
• IL-6–174 G/C and ApoE Gene Polymorphisms in Alzheimer’s and Vascular Dementia Patients Attending the Cognitive Disorder Clinic of the All India Institute of Medical Sciences, New Delhi

  2011cited by this paper
• The Role of Macrophage Migration Inhibitory Factor in Alzheimer’s Disease

  2010cited by this paper
• IFN-γ Promotes Complement Expression and Attenuates Amyloid Plaque Deposition in Amyloid β Precursor Protein Transgenic Mice

  2010cited by this paper
• Hepatocyte Growth Factor in Synaptic Plasticity and Alzheimer's Disease

  2010cited by this paper
• Growth factors and cytokines/chemokines as surrogate biomarkers in cerebrospinal fluid and blood for diagnosing Alzheimer's disease and mild cognitive impairment.

  2010cited by this paper
• Regulation of learning and memory by meningeal immunity: a key role for IL-4

  2010cited by this paper
• Peripheral inflammatory biomarkers of Alzheimer’s disease: the role of platelets

  2010cited by this paper
• Alzheimer's disease peptide β-amyloid interacts with fibrinogen and induces its oligomerization

  2010cited by this paper
• Biomarkers of oxidative damage and inflammation in Alzheimer's disease.

  2010cited by this paper
• Endothelin-1 is Elevated in Alzheimer's Disease Brain Microvessels and is Neuroprotective

  2010cited by this paper
• The vascular contribution to Alzheimer's disease.

  2010cited by this paper
• Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?

  2010cited by this paper
• Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

  2010cited by this paper
• A meta-analysis of cytokines in Alzheimer's disease.

  2010cited by this paper
• The complement system

  2010cited by this paper
• The role and therapeutic potential of monocytic cells in Alzheimer's disease

  2010cited by this paper
• The IL-17 Family Cytokines in Immunity and Disease

  2010cited by this paper
• Microglia and inflammation in Alzheimer's disease.

  2010cited by this paper
• Systemic Immune Responses in Alzheimer's Disease: In Vitro Mononuclear Cell Activation and Cytokine Production

  2010cited by this paper
• Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.

  2010cited by this paper
• Nerve growth factor as a paradigm of neurotrophins related to Alzheimer's disease

  2010cited by this paper

• A Review of Cutaneous Viral Infections and Their Potential Role in Neurologic Diseases

  2025cites this paper
• Navigating into the paradigm of lactoferrin surface modified nanocarriers in the management of central nervous system disorders

  2025cites this paper
• Unmasking a Paradox: Roles of the PD-1/PD-L1 Axis in Alzheimer's Disease-Associated Neuroinflammation

  2025cites this paper
• Antioxidant strategies against cellular senescence: unveiling the power of synthetic versus natural antioxidants in a systematic review

  2025cites this paper
• Effects of resistance exercise on behavioral and molecular changes in transgenic female mice for Alzheimer's disease in early and advanced stages.

  2025cites this paper
• Unveiling the Etiopathogenic Role of Epstein-Barr Virus in Periodontitis

  2025cites this paper
• Biomarkers of neuroinflammation and microcirculatory dysfunction in Alzheimer's disease: a comprehensive assessment of the pathogenetic and diagnostic role

  2025cites this paper
• Brain insulin resistance mediated cognitive impairment and neurodegeneration: Type-3 diabetes or Alzheimer’s Disease

  2025cites this paper
• Inflammatory biomarkers profiles and cognition among older adults

  2025cites this paper
• Baicalein's neuroprotective effects in a lansoprazole-induced Alzheimer's model in Wistar rats

  2025cites this paper
• Phytochemical analysis and neuroprotective potential of Achillea santolina L. fractions

  2025cites this paper
• Uncovering the intricacies of IGF-1 in Alzheimer’s disease: new insights from regulation to therapeutic targeting

  2025cites this paper
• Dissecting Causal Relationships Between Gut Microbiota Imbalance, Inflammatory Cytokines, and Structural Connectivity in the Brain: A Mendelian Randomization Study

  2025cites this paper
• Review on H3 Receptor Modulators: Future Pioneering approaches in Dementia Treatment

  2025cites this paper
• Efficacy and Safety of Bilateral Deep Brain Stimulation (DBS) for Severe Alzheimer's Disease: A Comparative Analysis of Fornix Versus Basal Ganglia of Meynert

  2025cites this paper
• Gut Microbiota and Alzheimer Disease.

  2025cites this paper
• Akkermansia muciniphila in neurological disorders: mechanisms and therapeutic potential via the gut-brain axis

  2025cites this paper
• Brain interleukins and Alzheimer’s disease

  2025cites this paper
• Fecal microbiota transplantation attenuates Alzheimer’s disease symptoms in APP/PS1 transgenic mice via inhibition of the TLR4-MyD88-NF-κB signaling pathway-mediated inflammation

  2025cites this paper
• Fritaipaines A - J, isosteroidal alkaloids with anti-neuroinflammatory activity from the bulbs of Fritillaria taipaiensis.

  2025cites this paper
• Newer Therapeutic Approaches in Treating Alzheimer’s Disease: A Comprehensive Review

  2025cites this paper
• Non-coding RNAs as key players in neurodegeneration and brain tumors: Insights into therapeutic strategies

  2025cites this paper
• Microglia-specific IL-10 gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson’s disease

  2024cites this paper
• Exploring the effect of gut microbiome on Alzheimer's disease

  2024cites this paper
• New neuroprotective derivatives of cinnamic acid by biotransformation.

  2024cites this paper
• Calcium Balance through Mutual Orchestrated Inter-organelle Communication: A Pleiotropic Target for Combating Alzheimer's Disease.

  2024cites this paper
• Omnidirectional improvement of mitochondrial health in Alzheimer's disease by multi-targeting engineered activated neutrophil exosomes.

  2024cites this paper
• The effect of physical exercise with cognitive training on inflammation and Alzheimer's disease biomarkers of Mild Cognitive Impairment patients

  2024cites this paper
• Pharmacological mTOR inhibitors in ameliorating Alzheimer’s disease: current review and perspectives

  2024cites this paper
• Prodromic Inflammatory–Oxidative Stress in Peritoneal Leukocytes of Triple-Transgenic Mice for Alzheimer’s Disease

  2024influential citation
• Dihydro‐resveratrol ameliorates NLRP3 inflammasome‐mediated neuroinflammation via Bnip3‐dependent mitophagy in Alzheimer's disease

  2024cites this paper
• Discovery of novel fatty acid amide hydrolase (FAAH) inhibitors as anti-alzheimer agents via in-silico-based drug design, virtual screening, molecular docking, molecular dynamics simulation, DFT, and non-clinical studies.

  2024cites this paper
• Exploring the mechanisms of kaempferol in neuroprotection: Implications for neurological disorders

  2024cites this paper
• Homocysteine decreases VEGF, EGF, and TrkB levels and increases CCL5/RANTES in the hippocampus: Neuroprotective effects of rivastigmine and ibuprofen.

  2024cites this paper
• Vascular Dysfunction in Alzheimer’s Disease: Alterations in the Plasma Contact and Fibrinolytic Systems

  2023cites this paper
• A Brief Overview of Neutrophils in Neurological Diseases

  2023cites this paper
• Effects of Current Psychotropic Drugs on Inflammation and Immune System.

  2023cites this paper
• The Adult Neurogenesis Theory of Alzheimer’s Disease

  2023cites this paper
• IL-6 Enhances the Negative Impact of Cortisol on Cognition among Community-Dwelling Older People without Dementia

  2023cites this paper
• Cortical-blood vessel assembloids exhibit Alzheimer’s disease phenotypes by activating glia after SARS-CoV-2 infection

  2023cites this paper
• Aqueous extract of Ceratonia siliqua L. leaves elicits antioxidant, anti‐inflammatory, and AChE inhibiting effects in amyloid‐β42‐induced cognitive deficit mice: Role of α7‐nAChR in modulating Jak2/PI3K/Akt/GSK‐3β/β‐catenin cascade

  2023cites this paper
• Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders

  2023cites this paper
• Effect of acupuncture on neuroinflammation in animal models of Alzheimer’s disease: A preclinical systematic review and meta-analysis

  2023cites this paper
• Pengaruh Pemberian Mesenchymal Stem Cells Wharton’s Jelly terhadap Ekspresi Gen PPAR-γ pada Tikus Alzheimer

  2023cites this paper
• New neuroprotective sesquiterpene lactate esters from carotol biotransformation

  2023cites this paper
• The Potent and Selective Histamine H3 Receptor Antagonist E169 Counteracts Cognitive Deficits and Mitigates Disturbances in the PI3K/AKT/GSK-3β Signaling Pathway in MK801-Induced Amnesia in Mice

  2023cites this paper
• Combinative effects of akarkara root-derived metabolites on anti-inflammatory and anti-alzheimer key enzymes: integrating bioassay-guided fractionation, GC-MS analysis, and in silico studies

  2023influential citation
• VRADA training system as a non-pharmacological dual intervention to alleviate symptoms of the pathophysiology of Mild Cognitive Impairment

  2023cites this paper
• Cell membrane-based nanomaterials for theranostics of central nervous system diseases

  2023cites this paper
• β-Amyloid targeting nanodrug for neuron-specific delivery of nucleic acids in Alzheimer's disease mouse models.

  2023cites this paper
• Mammalian Models in Alzheimer’s Research: An Update

  2023cites this paper
• THE POTENT AND SELECTIVE HISTAMINE H3 RECEPTOR ANTAGONIST E169 ALLEVIATES COGNITIVE DEFICITS AND MITIGATES DISTURBED PI3K/AKT/GSK-3Β SIGNALING PATHWAY IN MK801 -INDUCED AMNESIA IN MICE

  2023cites this paper
• An Alzheimer’s disease category progression sub-grouping analysis using manifold learning on ADNI

  2023cites this paper
• Nanotechnology-Based Drug Delivery For Alzheimer's And Parkinson's Diseases.

  2023cites this paper
• The extracts of Lobaria pindarensis, an edible lichen from Himalayas, suppress inflammatory response and fibrillation of amyloid β-protein in cultured microglial cells: Active depsidones, norstictic acid and stictic acid, are responsible for the functions

  2023cites this paper
• Role of GSK-3β Inhibitors: New Promises and Opportunities for Alzheimer’s Disease

  2023cites this paper
• Effects of gut microbiota on neurodegenerative diseases

  2023cites this paper
• Immunological evaluation of patients with Alzheimer's disease based on mitogen-stimulated cytokine productions and mitochondrial DNA indicators

  2023cites this paper
• Synthesis of mannan oligosaccharide-sialic acid conjugates and its inhibition on Aβ42 aggregation.

  2023cites this paper
• Effects of acupuncture on Alzheimer's disease: the mechanistic study

  2023cites this paper
• SRPK2 Expression and Beta-Amyloid Accumulation Are Associated With BV2 Microglia Activation

  2022cites this paper
• Probiotics Treatment Can Improve Cognition in Patients with Mild Cognitive Impairment: A Systematic Review

  2022cites this paper
• The Microbiome–Gut–Brain Axis and Dementia: A Bibliometric Analysis

  2022cites this paper
• Stem Cell-derived Extracellular Vesicles: A Promising Nano Delivery Platform to the Brain?

  2022cites this paper
• A new insight on feasibility of pre-, pro-, and synbiotics-based therapies in Alzheimer’s disease

  2022cites this paper
• Isolation of Phenolic Compounds from Raspberry Based on Molecular Imprinting Techniques and Investigation of Their Anti-Alzheimer’s Disease Properties

  2022cites this paper
• Trends in insulin resistance: insights into mechanisms and therapeutic strategy

  2022cites this paper
• Phenylethanoid Glycosides of Cistanche Improve Learning and Memory Disorders in APP/PS1 Mice by Regulating Glial Cell Activation and Inhibiting TLR4/NF-κB Signaling Pathway

  2022cites this paper
• Signature Effects of Vector-Guided Systemic Nano Bioconjugate Delivery Across Blood-Brain Barrier of Normal, Alzheimer’s, and Tumor Mouse Models

  2022cites this paper
• A role for flavonoids in the prevention and/or treatment of cognitive dysfunction, learning, and memory deficits: a review of preclinical and clinical studies

  2022cites this paper
• Type 3 diabetes (T3D) and alzheimer’s disease (AD)

  2022cites this paper
• Diagnostic Accuracy of Blood-Based Biomarker Panels: A Systematic Review

  2022cites this paper
• Poor Diet, Long Sleep, and Lack of Physical Activity Are Associated with Inflammation among Non-Demented Community-Dwelling Elderly

  2022cites this paper
• A Case of Early-Onset Alzheimer's Disease with MAPT P301L Mutation and Literature Review

  2022cites this paper
• Synthesis, characterization, molecular docking, dynamics simulations, and in silico absorption, distribution, metabolism, and excretion (ADME) studies of new thiazolylhydrazone derivatives as butyrylcholinesterase inhibitors

  2022cites this paper
• The impact of physical activity on blood inflammatory cytokines and neuroprotective factors in individuals with mild cognitive impairment: a systematic review and meta-analysis of randomized-controlled trials

  2022cites this paper
• Cellular and molecular influencers of neuroinflammation in Alzheimer's disease: Recent concepts & roles.

  2021cites this paper
• Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Aβ25-35-induced Alzheimer’s disease by inhibiting the phosphorylation of IκBα and p38

  2021cites this paper
• Factors associated with inflamm-aging in institutionalized older people

  2021cites this paper
• Lenalidomide beneficially alters IL-16 methylation status and IL-16 levels under rotenone insult in N9 cells

  2021cites this paper
• Inverse Correlation Between Alzheimer’s Disease and Cancer: Short Overview

  2021cites this paper
• GPR40 Agonist Ameliorate Pathological Neuroinflammation of Alzheimer’s Disease via the Modulation of Gut Microbiota and Immune System, a Mini-Review

  2021cites this paper
• Gastrointestinal (GI)-Tract Microbiome Derived Neurotoxins and their Potential Contribution to Inflammatory Neurodegeneration in Alzheimer’s Disease (AD)

  2021cites this paper
• Microglial TREM2 Mitigates Inflammatory Responses and Neuronal Apoptosis in Angiotensin II-Induced Hypertension in Middle-Aged Mice

  2021cites this paper
• Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.

  2021cites this paper
• Diet, inflammation, and neurocognitive aging

  2021cites this paper
• Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin-Induced Sporadic Alzheimer's Disease in Mice

  2021cites this paper
• Polysaccharide from Ganoderma lucidum ameliorates cognitive impairment by regulating the inflammation of the brain-liver axis in rats.

  2021cites this paper
• Nanotechnology-based drug delivery for central nervous system disorders.

  2021cites this paper
• Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson's diseases.

  2021cites this paper
• Enhancement of Insulin/PI3K/Akt Signaling Pathway and Modulation of Gut Microbiome by Probiotics Fermentation Technology, a Kefir Grain Product, in Sporadic Alzheimer’s Disease Model in Mice

  2021cites this paper
• Agathisflavone Modifies Microglial Activation State and Myelination in Organotypic Cerebellar Slices Culture

  2021cites this paper
• Advances in developing therapeutic strategies for Alzheimer's disease.

  2021cites this paper
• Diaportheone A Analogues Instigate a Neuroprotective Effect by Protecting Neuroblastoma SH-SY5Y Cells from Oxidative Stress

  2021cites this paper
• Plasma fatty acid abnormality in Sudanese drug-resistant epileptic patients.

  2021cites this paper
• Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease

  2021cites this paper
• Deep Brain Stimulation for Alzheimer's Disease: Stimulation Parameters and Potential Mechanisms of Action

  2021cites this paper
• The Neuroprotective Effect of Byu d Mar 25 in LPS-Induced Alzheimer's Disease Mice Model

  2021cites this paper
• Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

  2021cites this paper
• Neuroprotective effects on amyloid-beta induced cytotoxicity of Pandanus clementis Merr

  2021cites this paper